1. Home
  2. RWT vs CSTL Comparison

RWT vs CSTL Comparison

Compare RWT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$6.07

Market Cap

707.5M

Sector

Real Estate

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$24.54

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWT
CSTL
Founded
1994
2007
Country
United States
United States
Employees
351
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.5M
806.3M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RWT
CSTL
Price
$6.07
$24.54
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$6.91
$47.17
AVG Volume (30 Days)
1.4M
255.8K
Earning Date
04-27-2026
05-04-2026
Dividend Yield
11.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
$26.59
$2.42
Revenue Next Year
$22.21
$12.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.66
52 Week Low
$5.00
$14.59
52 Week High
$6.97
$44.28

Technical Indicators

Market Signals
Indicator
RWT
CSTL
Relative Strength Index (RSI) 62.09 42.64
Support Level $5.91 $21.77
Resistance Level $6.20 $26.44
Average True Range (ATR) 0.14 1.13
MACD 0.07 0.25
Stochastic Oscillator 95.38 56.85

Price Performance

Historical Comparison
RWT
CSTL

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: